ABSTRACT The clinical features of 208 patients with large cell anaplastic carcinoma of the bronchus are reviewed. Of the sample 47-6% had disseminated disease at presentation, and 95% were cigarette smokers. The median survival was 6'0 months and five-year-survival was 5-9%.
cell type. A different conclusion was reached by Walter and Pryce3 who reviewed 207 resection specimens and material from 159 postmortems. They divided the tumours into oat cell, squamous cell, adenocarcinoma, and a fourth anaplastic group that lacked squamous or glandular features and that did not resemble oat cell carcinoma. They suggested that this group might represent either anaplastic squamous carcinoma or adenocarcinoma. They found no convincingly mixed tumours. The cellular variability they did find in individual tumours was the result of secondary change within the tumour, and they concluded that histological types of bronchogenic carcinoma were distinct and not degrees of a spectrum.
For practical purposes a modified World Health Organisation classification5 is used by most histopathologists, the four common tumours being epidermoid, adenocarcinoma, small cell anaplastic carcinoma, and large cell carcinoma. This last group consists of large undifferentiated cells lacking features of the other three common tumours and lacking the special features of the rare pulmonary neoplasms. Prognosis and response to treatment depend on the histological type of tumour,6 7 and although there are many general large retrospective studies of bronchogenic car-cinoma,' 8 9 the natural history of each histological type is often not described separately. This is particularly so for large cell carcinoma which is usually considered together with small cell carcinoma. This is inappropriate, as small cell carcinoma is now understood to have a distinct cell of origin and biological behaviour.1011 On the other hand prospective studies of various treatments for carcinoma of the bronchus have focused attention on epidermoid, adeno, and small cell carcinoma of the bronchus. This study was, therefore, undertaken to clarify the natural history of large cell carcinoma of the bronchus. There was a statistically significant difference in survival between radiotherapy to the primary lesion and mediastinum, and patients receiving no treatment (<0 05, Mann-Whitney U test), but no statistically significant difference between palliative radiotherapy and patients receiving no treatment was observed. The difference in survival between patients receiving no treatment and those receiving surgery was highly significant (<0-001). The numbers in the other treatment groups were too small to allow statistical analysis.
Methods

Discussion
Ninety-five per cent of the patients in our series were smokers suggesting that large cell carcinoma is a smoking related disease. The age distribution was similar to other series of all histological types although women (mean age 56 years) were significantly younger than men (mean age 61 years) (<0-002). Four per cent of patients were asymptomatic. In those with symptoms 50% had dull intermittent chest pain and nearly one-third had haemoptysis. There were no physical signs in 23% at presentation. This may reflect the tendency of the disease to arise in the lung periphery'2 13 Clinically, bone and CNS involvement were rare at presentation but common at death. Ninety-eight per cent of patients had an abnormality on chest radiograph and of these 43% had a peripheral abnormality alone. This confirms Byrd's and colleagues finding of a solitary peripheral abnormality in 40% of 93 patients with large cell carcinoma, in contrast to squamous cell carcinoma where only 24% had peripheral abnormality alone.'2 13 In our series, site and extent of chest radiograph abnormality did not affect survival. Forty-two per cent were diagnosed at bronchoscopy and 14% had positive sputum cytology. These figures are low compared with series of other histological types and may reflect the peripheral nature of the disease, and, in the case of sputum cytology,14 possibly large cell carcinoma does not exfoliate as readily as epidermoid and small cell carcinoma.
The five-year-survival figure for the whole group of 5.9% is lower than that reported for squamous carcinoma or adenocarcinoma,6 7 but similar to that reported for small cell carcinoma." The median survival for patients who received no treatment was 2*5 months, similar to small cell carcinoma, 2-3 months, and survival was not affected by staging at presentation. This group cannot be used as a control as they were a selected group either because they were too ill to receive treatment, declined treatment, or were found to be inoperable at thoracotomy. Radiotherapy produced very poor survival figures. Large cell carcinoma has been reported to be more radiosensitive than epidermoid or adenocarcinoma.15 It is, therefore, surprising that there were no five-year radiotherapy survivors, as long-term survival has been reported with epidermoid and small cell carcinoma.'6 Radiotherapy prolonged survival when compared with untreated patients but, as already pointed out, the untreated group cannot be used as a control, and treatment with radiotherapy presupposes a minimum of four weeks survival from diagnosis. The poor radiotherapy results in this series suggest that the tumour is not very radiosensitive.
No conclusion can be drawn from the chemotherapy group because of the small numbers of patients and varied drug regimens used. However, large cell carcinoma has similarities with small cell carcinoma (which has been reported to be responsive to chemotherapy'7) as the untreated survival time is short, and both are disseminated in the majority of cases at presentation.
In 27% of patients it was possible to resect tumour surgically. These patients had a five-yearsurvival of 21% which compares favourably with epidermoid carcinoma6 18 
